Tagged with France,

France Philippe Truelle, President of CDM Lavoisier, highlights the financial impact of the EU’s Falsified Medicines Directive (FMD) on SMEs across Europe and explains how France is becoming increasingly attractive to foreign investors under the Macron Presidency. He also speaks out about CDM Lavoisier’s longstanding legacy in France and outlines the…

France Frédéric Collet, president Novartis France and general manager oncology explains the rationale behind Novartis’s consistent investment in France, the current shift in the company’s corporate culture and the main challenges inherent to the unprecedented wave of innovation that is revolutionizing the health industry.   In terms of research, we have invested EUR…

France In this exclusive interview, David Loew, executive vice president of Sanofi Pasteur, discusses the future of vaccines in France and the rest of the world, their strategic role in reducing public healthcare expenditure and the revolutionary force of machine learning that promises to disrupt the vaccines space.   Vaccination is…

France Nicolas Bardonnet of Promega France discusses the standout growth of the company on the occasion of its 40th anniversary, collaboration with France’s biotech clusters and the growth drivers of the future.   In France, we start to see hospitals coming to us, but also clinical diagnostic laboratories because for a…

France Professor Alexander Eggermont, general director of Gustave Roussy, gives insights into the transformation of the Hospital under his ten-year leadership mandate. He also explains the rationale behind creating Cancer Core Europe, a collaborative platform of Europe’s seven leading cancer institutes.   Our system brings between 3500 and 4000 patients into…

Europe The Top Pharma Markets in Europe for 2016 according to the latest EFPIA figures. Germany leads the way, with a market size of EUR 30.815 billion, followed by France and Italy.

France Jean-Luc Belingard, president of FEFIS (Fédération Française des Industries de Santé – French Federation of the Health Industry), explains his role following up on the implementation of the CSIS (Conseil stratégique des industries de santé – Strategic council of the healthcare industry) and speaks out about the competitiveness of the…

France Jean-Yves Berthon, CEO of French plant biotechnology pioneers GREENTECH discusses the key milestones in the company’s development trajectory, diversification plans and potential M&A activity.   Our speciality is the extraction, purification and concentration of active molecules derived from plant matter and sourced from expert growers from more than 40 countries…

France Eric Del Cotto, general manager of Owen Mumford Southern Europe and Northern Africa, explains the challenges in market access for SMEs in France. He also gives an overview of Owen Mumford’s history and future strategy in the country, including consideration of the impact of Brexit.     How would you…

France   LEEM – Les Entreprises du Médicament (Drug Companies)   Key people: Philippe Tcheng, President Philippe Lamoureux, Director LEEM is the French industry association which represents drug companies operating in France and is the most powerful professional organization of drug companies operating in the country. They represent more than 260 member companies,…

France ANSM – Agence Nationale de Sécurité des Médicaments et des Produits de Santé (National Agency for the Safety of Drugs and Health Products)   Key People: Dominique Martin, CEO The National Agency for the Safety of Medicines and Health Products (ANSM) was created by the government in 2011 for strengthening the safety of…

France Marc Julien, co-CEO of Diabeloop, presents the revolutionary “artificial pancreas” the company has developed to support type one diabetes patients. The device embeds artificial intelligence to help type one diabetics regulate their insulin intake according to their needs. He also discusses the opportunities and challenges he sees to bring such…